"This is what the beginning of a new bull market looks like," Morgan Stanley's CIO said, adding that earnings look resilient ...

Morgan Stanley's profit beat Wall Street estimates in the second quarter as its traders cashed in on volatile markets, but ...

Morgan Stanley (NYSE:MS) on Wednesday reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating ...

Morgan Stanley’s stock traders posted their best second quarter on record as the biggest US banks continue to reap the benefits of market volatility tied to President Donald Trump’s policy moves.

Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy now. On July 10, Morgan Stanley analyst Terrence ...

Morgan Stanley closed 2.46% short of its 52-week high of $145.16, which the company achieved on July 7th.

Goldman Sachs posted the largest quarterly stock-trading bonanza in its history, as banks across Wall Street bagged fat ...

Joint Stock Company Kaspi.kz (NASDAQ:KSPI) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On June 17, ...

Amicus Therapeutics (FOLD) stock gains as Morgan Stanley upgrades, citing a favorable patent dispute setup and potential for its Pompe disease therapy. Read more here.

Morgan Stanley’s stock (NYSE: MS) has lost approximately 7% YTD, as compared to the 9% rise in the S&P500 over the same period. Further, the stock price decreased 5.2% yesterday vs a 0.74% ...

Morgan Stanley’s stock has gained 34% YTD, and at its current price of $92 per share, it is trading slightly above its fair value of 89 – Trefis’ estimate for Morgan Stanley’s valuation.